Enhancing Skin Cancer Early Detection and Treatment in Primary Care

NCT05675709 | Completed Results

• 3 other identifiers: STUDY00024809NCI-2022-09484P50CA244289
• Study Type: interventional
• Target: 54
• Locations: 1 country
• Sites: 1

Brief Summary

Skin cancer screening may help find melanoma sooner, when it may be easier to treat. If found early melanoma and other types of skin cancer may be curable. Multi-component education may be an effective method to help primary care physicians (PCPs) learn about skin cancer screening. This clinical trial examines whether a clinician-focused educational intervention can improve PCP's knowledge and clinical performance to identify and triage skin cancer. This intervention may increase the PCP's ability to diagnose, treat and/or triage early-stage melanoma.

Conditions

Cutaneous Melanoma

Outcome Measures

Primary Outcomes (3)

• Change in Clinician Knowledge in Melanoma Risk and Lesion Identification

  KnChange in melanoma risk, knowledge based upon survey questions prior to training and post-training. Content covered melanoma risk, knowledge of electronic health record tools specific to the training and lesion identification and biopsy procedure knowledge. A total score of correct responses for the 27 items was generated and transformed to represent the percent of correct items with zero being no correct items and 100% being all items correct. A change score from pre-training to post-training was generated where a positive change score represented the gain in knowledge in percent points and a negative change score representing a lower percent of correct responses from pre-training to post-training.

  Immediately before and after the training session

• Dermatology Referral

  Mean percent of dermatology referrals per 1000 patients

  minimum of 3 months and up to 1 year of EHR data for each clinician prior to the start of the training and the same months in the year post-training.

• Use of Dermatology E-consults

  number of dermatology e-consults

  minimum of 3 months and up to 1 year of EHR data for each clinician prior to the start of the training and the same months in the year post-training.

Study Arms (2)

Comparison group

NO INTERVENTION

PCPs at the two clinics who do not receive the group training will serve as study comparators.

Other, Pragmatic

EXPERIMENTAL

PCP participants complete group training. All training participants will also be offered series of short booster teaching points delivered virtually. Participants who complete the training also take part in pre-post knowledge assessments. PCP participants may also participate in a qualitative interview.

Behavioral: Training and Education

Interventions

Training and Education BEHAVIORAL

Undergo group trainings

Other, Pragmatic

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Clinicians at two Oregon Health \& Science University (OHSU) primary care clinics will be invited to receive exposure to the melanoma early detection intervention
• Clinicians at the two clinics who do not receive the intervention will serve as study comparators
• These individuals are all aged 18 years or older
• All practice members speak English

You may not qualify if:

• No one will be intentionally excluded

Sponsors & Collaborators

• OHSU Knight Cancer Institute: lead
• Oregon Health and Science University: collaborator
• National Cancer Institute (NCI): collaborator

Study Sites (1)

OHSU Knight Cancer Institute

Portland, Oregon, 97239, United States

Location

MeSH Terms

Conditions

Melanoma

Interventions

Educational Status

Condition Hierarchy (Ancestors)

Neuroendocrine Tumors; Neuroectodermal Tumors; Neoplasms, Germ Cell and Embryonal; Neoplasms by Histologic Type; Neoplasms; Neoplasms, Nerve Tissue; Nevi and Melanomas; Skin Neoplasms; Neoplasms by Site; Skin Diseases; Skin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Socioeconomic Factors; Population Characteristics

Limitations and Caveats

The initial plan to randomize pods of clinicians within each of the two clinics proved not to be feasible and participation in the training module was much lower than expected.

Results Point of Contact

• Title: Susan Flocke
• Organization: Oregon Health & Science University

fmresrch@ohsu.edu

503 494 4404

Study Officials

• Susan A Flocke, Ph.D.

  OHSU Knight Cancer Institute

  PRINCIPAL INVESTIGATOR

Publication Agreements

• PI is Sponsor Employee: No
• Restrictive Agreement: No

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: SCREENING
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: December 29, 2022
• First Posted: January 9, 2023
• Study Start: April 25, 2023
• Primary Completion: June 30, 2024
• Study Completion: June 30, 2024
• Last Updated: December 8, 2025
• Results First Posted: December 8, 2025

Record last verified: 2025-06

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)